So in the part A of the GBM trial will — because it’s a Phase 2 dose escalation trial primary endpoints of course are first of all to look at safety intolerability and then we do have ...

Patients in the study are treated until disease progression or intolerability. The primary endpoint of the study is 16-week progression free survival (“PFS”), and secondary endpoints include ...

By reducing these symptoms, a patient's physical function can be improved. In some patients, intolerability to NSAIDs can limit the options for treating their OA symptoms. All NSAIDs carry a risk ...

and subjective measures of intolerability (nausea) are not.32 This highlights a limitation of the current study, in that the data were originally collected for the purpose of analysing longitudinal ...

With that said, only around 4% of users report significant side effects. Of these, roughly one in 10 will stop treatment due to drug intolerability. The U.S. Food and Drug Administration (FDA) has ...

The patients' adherence to anti-rheumatic therapy was significantly (p<0.1) higher in group I whereas stopping DMARDs for intolerability was significantly (p<0.01) higher in group II at both 6- and 12 ...

Retinoids like adapalene and retinol are used for a range of skin-related purposes, such as acne and anti-aging. Learn more ...

Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. A question ...

Am J Health Syst Pharm. 2008;65(24):2347-2357. Administer medications via the oral route when possible. Determine the enteral feeding tube size (e.g., small bore or large bore), insertion site (e ...